GHIGLIAZZA, GABRIELE
GHIGLIAZZA, GABRIELE
Universita' degli Studi di MILANO
Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis
2024 J. Vidal-González, J. Martínez, A. Mulay, M. López, A. Baiges, A. Elmahdy, K. Lampichler, G. Maleux, J. Chang, M. Poncela, G. Low, G. Ghigliazza, A. Zipprich, C. Picón, R. Shah, E. Llop, A. Darnell, M.H. Maurer, L. Bonne, E. Ramón, S. Quiroga, J.G. Abraldes, A. Krag, J. Trebicka, C. Ripoll, V. La Mura, P. Tandon, R. García-Martínez, M. Praktiknjo, W. Laleman, T. Reiberger, A. Berzigotti, V. Hernández-Gea, J.L. Calleja, E.A. Tsochatzis, A. Albillos, M. Simón-Talero, J. Genescà
Anemia management and transfusion strategy in internal medicine units: Less is more
2023 D. Blanca, G. Parrella, D. Consonni, S. Villa, G. Ceriani, A. Cespiati, G. Figini, G. Ghigliazza, D. Maira, G. Oberti, N. Scaramellini, G.L. Schinco, F. Tafuri, N. Montano, M.D. Cappellini, I. Motta
Improving management of portal hypertension: the potential benefit of non-etiological therapies in cirrhosis
2023 N. Bitto, G. Ghigliazza, S. Lavorato, C. Caputo, V. La Mura
Increased risk of urticaria/angioedema after BNT162b2 mRNA COVID-19 vaccine in health care workers taking ACE inhibitors
2021 M. Cugno, D. Consonni, A. Lombardi, P. Bono, M. Oggioni, S.U. Renteria, A.C. Pesatori, S. Castaldi, L. Riboldi, L. Bordini, C.D. Nava, F. Ceriotti, A. Torri, F. Tafuri, G. Ghigliazza, F. Peyvandi, A. Bandera, A. Gori
Mortality in Patients with COVID-19 on Renin Angiotensin System Inhibitor Long-Term Treatment : An Observational Study Showing that Things Are Not Always as They Seem
2021 M. Cugno, R. Gualtierotti, G. Casazza, F. Tafuri, G. Ghigliazza, A. Torri, G. Costantino, N. Montano, F. Peyvandi
Acute Portal Vein Thrombosis in SARS-CoV-2 Infection: A Case Report
2020 V. La Mura, A. Artoni, I. Martinelli, R. Rossio, R. Gualtierotti, G. Ghigliazza, S. Fusco, A.M. Ierardi, M.C. Andrisani, G. Carrafiello, F. Peyvandi